Clough Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,888
Closed -$9.65M 147
2024
Q3
$9.65M Sell
10,888
-16,904
-61% -$15.2M 0.99% 39
2024
Q2
$25.2M Buy
27,792
+1,377
+5% +$1.1M 2.75% 8
2024
Q1
$20.5M Buy
+26,415
New +$18.8M 2.26% 10
2023
Q2
Sell
-13,320
Closed -$4.57M 184
2023
Q1
$4.57M Buy
13,320
+3,620
+37% +$1.22M 0.49% 74
2022
Q4
$3.55M Buy
+9,700
New +$3.44M 0.36% 74
2022
Q3
Sell
-6,013
Closed -$1.95M 94
2022
Q2
$1.95M Sell
6,013
-6,000
-50% -$1.8M 0.24% 52
2022
Q1
$3.44M Hold
12,013
0.26% 75
2021
Q4
$3.32M Hold
12,013
0.22% 72
2021
Q3
$2.78M Hold
12,013
0.17% 79
2021
Q2
$2.76M Buy
12,013
+2,800
+30% +$562K 0.15% 93
2021
Q1
$1.72M Hold
9,213
0.08% 101
2020
Q4
$1.56M Hold
9,213
0.11% 90
2020
Q3
$1.36M Hold
9,213
0.1% 87
2020
Q2
$1.51M Buy
9,213
+1,800
+24% +$276K 0.15% 95
2020
Q1
$1.03M Hold
7,413
0.1% 79
2019
Q4
$974K Hold
7,413
0.08% 86
2019
Q3
$829K Sell
7,413
-1,400
-16% -$156K 0.07% 81
2019
Q2
$976K Hold
8,813
0.1% 86
2019
Q1
$1.14M Sell
8,813
-1,387
-14% -$169K 0.1% 94
2018
Q4
$1.18M Buy
+10,200
New +$1.14M 0.14% 96

Other funds holding LLY

Clough Capital Partners's LLY Position: Q4 2024 in Review

Clough Capital Partners sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 10,888 shares — an estimated $9.65M sold.

Clough Capital Partners first reported a position in LLY in Q4 2018 and held it in 20 quarters. The position peaked at $25.2M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Clough Capital Partners reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Clough Capital Partners sold 10,888 Eli Lilly shares in Q4 2024, an estimated $9.65M.
  • Clough Capital Partners first reported a position in Eli Lilly in Q4 2018 and held it in 20 quarters.
  • Clough Capital Partners's Eli Lilly position peaked at $25.2M in Q2 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Clough Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.